Exhibitor

CTI is a global, privately held, full-service CRO, focused on rare diseases, cell & gene therapy, transplant medicine of solid organs and stem cells, as well as liver and kidney diseases in adults and children. CTI is one of the 20 largest CROs in the world, executing trials in more than 60 countries, including the Middle East/Africa region, and has contributed to more than 120 new drug and device approvals through global regulatory agencies such as the FDA and EMA.